We only have this paper's title and publication details.
Read it at the sourcePhase I/II trial shows improved duration of response in advanced lung cancer, highlighting synergy of combined therapies.
Supplementary Figure 2. Kaplan-Meier estimation of DOR.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: